These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34120271)

  • 21. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in the Russian Population.
    Evdoshenko E; Laskova K; Shumilina M; Nekrashevich E; Andreeva M; Neofidov N; Kalinin I; Nikitchenko D; Rogozina A; Kupaeva A; Bulanov I; Bakirtzis C; Grigoriadis N; Khachanova N; Davydovskaya M; Makshakov G
    J Int Neuropsychol Soc; 2022 May; 28(5):503-510. PubMed ID: 34132190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sub-threshold cognitive impairment in multiple sclerosis: the association with cognitive reserve.
    Feinstein A; Lapshin H; O'Connor P; Lanctôt KL
    J Neurol; 2013 Sep; 260(9):2256-61. PubMed ID: 23736972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis.
    Calabrese M; Agosta F; Rinaldi F; Mattisi I; Grossi P; Favaretto A; Atzori M; Bernardi V; Barachino L; Rinaldi L; Perini P; Gallo P; Filippi M
    Arch Neurol; 2009 Sep; 66(9):1144-50. PubMed ID: 19752305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brief International Cognitive Assessment for Multiple Sclerosis scores are associated with the cortical thickness of specific cortical areas in relapsing-remitting patients.
    Davion JB; Lopes R; Jougleux C; Viard R; Dumont J; Leclerc X; Outteryck O
    Rev Neurol (Paris); 2022 Apr; 178(4):326-336. PubMed ID: 34657733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropsychological profiles comparison between Multiple Sclerosis patients and Multiple Sclerosis patients with overlapping features of Systemic Lupus Erythematosus.
    Stavrogianni K; Kitsos DK; Giannopapas V; Chasiotis AK; Christouli N; Paraskevas PG; Zompola C; Tsivgoulis G; Paraskevas GP; Giannopoulos S
    J Neuroimmunol; 2024 Feb; 387():578270. PubMed ID: 38176314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abnormalcortical thickness in relapsing-remitting multiple sclerosis, correlations with cognition impairment, and effect of modified Bushenyisui decoction on cognitive function of multiple sclerosis.
    Zhao X; Yang T; Cheng F; Yang S; Zhu W; Li S; Fan Y
    J Tradit Chin Med; 2021 Apr; 41(2):316-325. PubMed ID: 33825413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Greek population with multiple sclerosis.
    Polychroniadou E; Bakirtzis C; Langdon D; Lagoudaki R; Kesidou E; Theotokis P; Tsalikakis D; Poulatsidou K; Kyriazis O; Boziki M; Papadopoulos G; Boura E; Sintila L; Hatzigeorgiou S; Ziamos C; Ioannidis P; Karacostas D; Grigoriadis N
    Mult Scler Relat Disord; 2016 Sep; 9():68-72. PubMed ID: 27645348
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive impairment and decline in different MS subtypes.
    Huijbregts SC; Kalkers NF; de Sonneville LM; de Groot V; Polman CH
    J Neurol Sci; 2006 Jun; 245(1-2):187-94. PubMed ID: 16643951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insulin resistance is associated with cognitive dysfunction in multiple sclerosis patients: A cross-sectional study.
    Ayromlou H; Hosseini S; Khalili M; Ayromlou S; Khamudchiyan S; Farajdokht F; Hassannezhad S; Amiri Moghadam S
    J Neuroendocrinol; 2023 Jun; 35(6):e13288. PubMed ID: 37317829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.
    Migliore S; Ghazaryan A; Simonelli I; Pasqualetti P; Squitieri F; Curcio G; Landi D; Palmieri MG; Moffa F; Filippi MM; Vernieri F
    Behav Neurol; 2017; 2017():7404289. PubMed ID: 28912625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a Brief Computerized Cognitive Assessment in Multiple Sclerosis (BCCAMS) and comparison with reference batteries.
    Maubeuge N; Deloire MS; Brochet B; Charré-Morin J; Saubusse A; Ruet A
    Mult Scler; 2022 Jun; 28(7):1112-1120. PubMed ID: 34766866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting Neuropsychological Impairment in Relapsing Remitting Multiple Sclerosis: The Role of Clinical Measures, Treatment, and Neuropsychiatry Symptoms.
    Lozano-Soto E; Cruz-López ÁJ; Gutiérrez R; González M; Sanmartino F; Rashid-Lopez R; Espinosa-Rosso R; Forero L; González-Rosa JJ
    Arch Clin Neuropsychol; 2021 May; 36(4):475-484. PubMed ID: 33067616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association between cognition and motor performance is beyond structural damage in relapsing-remitting multiple sclerosis.
    Mistri D; Cacciaguerra L; Storelli L; Meani A; Cordani C; Rocca MA; Filippi M
    J Neurol; 2022 Aug; 269(8):4213-4221. PubMed ID: 35278104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropsychological characteristics of benign multiple sclerosis patients: A two-year matched cohort study.
    Hegedüs K; Kárpáti J; Iljicsov A; Simó M
    Mult Scler Relat Disord; 2019 Oct; 35():150-155. PubMed ID: 31376686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Information processing speed and influential factors in multiple sclerosis].
    Zhang ML; Xu EH; Dong HQ; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utilization of the auditory consonant trigram test to screen for cognitive impairment in patients with multiple sclerosis: comparison with the paced auditory serial addition test.
    Ozakbas S; Ormeci B; Akdede BB; Alptekin K; Idiman E
    Mult Scler; 2004 Dec; 10(6):686-9. PubMed ID: 15584495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity of conventional memory tests in multiple sclerosis: comparing the Rao Brief Repeatable Neuropsychological Battery and the Minimal Assessment of Cognitive Function in MS.
    Strober L; Englert J; Munschauer F; Weinstock-Guttman B; Rao S; Benedict RH
    Mult Scler; 2009 Sep; 15(9):1077-84. PubMed ID: 19556311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations between functional capacity, isokinetic leg strength, sleep quality and cognitive function in multiple sclerosis patients: a cross-sectional study.
    Aristotelous P; Stefanakis M; Pantzaris M; Pattichis C; Hadjigeorgiou GM; Giannaki CD
    Postgrad Med; 2019 Sep; 131(7):453-460. PubMed ID: 31469966
    [No Abstract]   [Full Text] [Related]  

  • 39. The degree of cortical plasticity correlates with cognitive performance in patients with Multiple Sclerosis.
    Balloff C; Penner IK; Ma M; Georgiades I; Scala L; Troullinakis N; Graf J; Kremer D; Aktas O; Hartung HP; Meuth SG; Schnitzler A; Groiss SJ; Albrecht P
    Brain Stimul; 2022; 15(2):403-413. PubMed ID: 35182811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measures of Thalamic Integrity are Associated with Cognitive Functioning in Fingolimod-treated Multiple Sclerosis Patients.
    Conway DS; Planchon SM; Oh SH; Nakamura K; Thompson NR; Sakaie K; Ontaneda D
    Mult Scler Relat Disord; 2021 Jan; 47():102635. PubMed ID: 33260053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.